News Feed Item
GE Healthcare Announces European Union Approval of VIZAMYL™ (Flutemetamol (18F) Solution for Injection) for PET Imaging of Beta Amyloid Plaque in Suspected Alzheimer’s Disease
|By Business Wire
|September 1, 2014 03:00 AM EDT
GE Healthcare announced today that VIZAMYL™ (flutemetamol (18F)
solution for injection) has received marketing authorisation from the
European Commission as a radiopharmaceutical medicinal product indicated
for Positron Emission Tomography (PET) imaging of beta amyloid neuritic
plaque density in the brains of adult patients with cognitive impairment
who are being evaluated for Alzheimer’s disease (AD) and other causes of
cognitive impairment. VIZAMYL™ is the only PET imaging tracer for
detection of amyloid approved in Europe for visual interpretation of
colour images and will be commercially available in selected European
countries from early 2015. VIZAMYL™ is for diagnostic use only and
should be used in conjunction with a clinical evaluation.
VIZAMYL™ PET cases showing examples of negative flutemetamol (18F) PET scan (left) and positive scan (right). Images from VIZAMYL, European Summary of Product Characteristics. Reference: http://www.ema.europa.eu/ema Date: August 2014
“Dementia is one of the biggest health and social challenges in the
world and receiving marketing authorisation for VIZAMYL in the European
Union (EU) demonstrates our continued commitment to helping to meet this
challenge and support the diagnosis of Alzheimer’s disease” said Kieran
Murphy, President and CEO, Life Sciences, GE Healthcare. “This approval
will provide physicians in the EU with an important tool that may
help them better assess specific patients who are being evaluated for
Alzheimer’s disease and will also support further research into greatly
needed disease modifying agents.”
Alzheimer's disease, the leading cause of dementia, can be challenging
to diagnose, as many of the symptoms are similar to other causes of
cognitive impairment1. When used in conjunction with a
clinical evaluation, using VIZAMYL to detect the accumulation of beta
amyloid in the brain may help to confirm an Alzheimer’s disease
diagnosis and could potentially have an impact on earlier patient
management, including the treatment of symptoms.
“VIZAMYL can help with diagnosis in certain individuals, providing
patients and caregivers, along with their healthcare professionals, the
opportunity to determine appropriate treatment options and plan for the
future,” said Professor Philip Scheltens, Professor of Cognitive
Neurology and Director of the Alzheimer Center at the VU University
Medical Center, Amsterdam. “Because Alzheimer’s disease and dementia
continue to be a major burden on healthcare and society, it is equally
important that VIZAMYL will help support and guide further clinical
research that is vital in order to develop disease modifying agents.”
Even though disease modifying agents are not yet available, new
research released from the GE Healthcare-sponsored Value of Knowing
Survey 20142 revealed an overwhelming demand to know about a
neurological diagnosis in oneself or their loved ones, even in absence
of a cure. The survey found that 74% of respondents would want to know
their neurological disease diagnosis, even if there is no cure, and 81%
would want to know the diagnosis if someone close to them had an
incurable neurological disorder. The ‘Value of Knowing’ is a global
survey of 10,000 adults across 10 countries exploring perspectives on
incurable neurological disorders including Alzheimer’s (AD) and
Parkinson’s (PD). The research was conducted by Millward Brown during
June 2014 across 10 countries – Australia, Brazil, China, India,
Indonesia, Japan, Russia, South Korea, UK and USA – with 1,000
nationally –representative adult respondents in each market.
The marketing authorisation for VIZAMYL was based on review of
data from a series of Phase III clinical trials, including brain autopsy
studies which showed high sensitivity and specificity for visual
interpretation of flutemetamol (18F) PET images, using beta
amyloid pathology as the standard of truth.3,4 Additionally,
to instruct physicians in accurate interpretation of VIZAMYL images, GE
Healthcare has developed an electronic reader training program (ETP),
which, following approval, will be offered free of charge as online and
in-person training in the European Union. Images should be interpreted
only by readers who have completed the GE Healthcare electronic reader
GE’S COMMITMENT TO IMAGING RESEARCH
VIZAMYL, flutemetamol (18F) is one component of a broad
portfolio of investigational diagnostic solutions that GE Healthcare is
currently developing in the neurology field. GE Healthcare is taking a
comprehensive approach to understanding dementia and AD through its
ongoing research to uncover the causes, risks, and physical effects of
these diseases. GE Healthcare offers a broad portfolio of imaging
resources including cyclotrons and chemistry systems to manufacture PET
imaging agents, PET and MR scanners to scan patients, and is developing
image analysis software to provide quantification, optimized
visualization and reporting tools.
Additionally, GE Healthcare is collaborating with other companies in the
pharmaceutical industry to assist in their development of the next
generation of therapies. To that end, work is ongoing with potential
partners in the industry to understand their strategic needs, and
helping to provide imaging support for clinical trials of therapeutic
ABOUT GE HEALTHCARE
GE Healthcare provides transformational medical technologies and
services to meet the demand for increased access, enhanced quality and
more affordable healthcare around the world. GE (NYSE: GE) works on
things that matter - great people and technologies taking on tough
challenges. From medical imaging, software & IT, patient monitoring and
diagnostics to drug discovery, biopharmaceutical manufacturing
technologies and performance improvement solutions, GE Healthcare helps
medical professionals deliver great healthcare to their patients.
For our latest news, please visit http://newsroom.gehealthcare.com
1Alzheimer’s Association. What is Dementia Patient
Information. Available at http://www.alz.org/what-is-dementia.asp.
Last accessed August 2014.
2 Value of Knowing 2014. GE Healthcare. Data on file.
3 Ikonomovic M, Buckley C, Smith A et al. [18F]Flutemetamol
injection PET images reflect brain amyloid levels. Data presented at
Alzheimer's Association® International Conference 2012 (AAIC
2012), Vancouver, BC, Canada.
4 Wolk D, Gamez J, Sadowsky C et. al. Brain autopsy and in
vivo cortical brain biopsy trials show a strong concordance between [18F]Flutemetamol
PET and amyloid-β pathology. Poster presented at: 64th Annual Meeting of
the American Academy of Neurology, April 21-28, 2012; New Orleans, LA.
Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20140901005048/en/
SYS-CON Events announced today that Ericsson has been named “Gold Sponsor” of SYS-CON's @ThingsExpo, which will take place on June 7-9, 2016, at the Javits Center in New York, New York.
Ericsson is a world leader in the rapidly changing environment of communications technology – providing equipment, software and services to enable transformation through mobility.
Some 40 percent of global mobile traffic runs through networks we have supplied. More than 1 billion subscribers around the world re...
May. 4, 2016 11:15 AM EDT Reads: 1,303
There is an ever-growing explosion of new devices that are connected to the Internet using “cloud” solutions. This rapid growth is creating a massive new demand for efficient access to data. And it’s not just about connecting to that data anymore.
This new demand is bringing new issues and challenges and it is important for companies to scale for the coming growth. And with that scaling comes the need for greater security, gathering and data analysis, storage, connectivity and, of course, the...
May. 4, 2016 11:15 AM EDT Reads: 1,207
SYS-CON Events announced today that Peak 10, Inc., a national IT infrastructure and cloud services provider, will exhibit at SYS-CON's 18th International Cloud Expo®, which will take place on June 7-9, 2016, at the Javits Center in New York City, NY.
Peak 10 provides reliable, tailored data center and network services, cloud and managed services. Its solutions are designed to scale and adapt to customers’ changing business needs, enabling them to lower costs, improve performance and focus inter...
May. 4, 2016 11:00 AM EDT Reads: 1,400
Increasing IoT connectivity is forcing enterprises to find elegant solutions to organize and visualize all incoming data from these connected devices with re-configurable dashboard widgets to effectively allow rapid decision-making for everything from immediate actions in tactical situations to strategic analysis and reporting.
In his session at 18th Cloud Expo, Shikhir Singh, Senior Developer Relations Manager at Sencha, will discuss how to create HTML5 dashboards that interact with IoT devic...
May. 4, 2016 11:00 AM EDT Reads: 1,374
We’ve worked with dozens of early adopters across numerous industries and will debunk common misperceptions, which starts with understanding that many of the connected products we’ll use over the next 5 years are already products, they’re just not yet connected. With an IoT product, time-in-market provides much more essential feedback than ever before. Innovation comes from what you do with the data that the connected product provides in order to enhance the customer experience and optimize busi...
May. 4, 2016 11:00 AM EDT Reads: 1,277
SYS-CON Events announced today the Docker Meets Kubernetes – Intro into the Kubernetes World, being held June 9, 2016, in conjunction with 18th Cloud Expo | @ThingsExpo, at the Javits Center in New York, NY.
Register for 'Docker Meets Kubernetes Workshop' Here!
This workshop led by Sebastian Scheele, co-founder of Loodse, introduces participants to Kubernetes (container orchestration). Through a combination of instructor-led presentations, demonstrations, and hands-on labs, participants learn ...
May. 4, 2016 10:30 AM EDT Reads: 291
See storage differently! Storage performance problems have only gotten worse and harder to solve as applications have become largely virtualized and moved to a cloud-based infrastructure. Storage performance in a virtualized environment is not just about IOPS, it is about how well that potential performance is guaranteed to individual VMs for these apps as the number of VMs keep going up real time.
In his session at 18th Cloud Expo, Dhiraj Sehgal, in product and marketing at Tintri, will discu...
May. 4, 2016 10:00 AM EDT Reads: 1,013
So, you bought into the current machine learning craze and went on to collect millions/billions of records from this promising new data source. Now, what do you do with them? Too often, the abundance of data quickly turns into an abundance of problems. How do you extract that "magic essence" from your data without falling into the common pitfalls?
In her session at @ThingsExpo, Natalia Ponomareva, Software Engineer at Google, will provide tips on how to be successful in large scale machine lear...
May. 4, 2016 10:00 AM EDT Reads: 1,499
Peak 10, Inc., has announced the implementation of IT service management, a business process alignment initiative based on the widely adopted Information Technology Infrastructure Library (ITIL) framework. The implementation of IT service management enhances Peak 10’s current service-minded approach to IT delivery by propelling the company to deliver higher levels of personalized and prompt service. The majority of Peak 10’s operations employees have been trained and certified in the ITIL frame...
May. 4, 2016 10:00 AM EDT Reads: 1,133
The increasing popularity of the Internet of Things necessitates that our physical and cognitive relationship with wearable technology will change rapidly in the near future. This advent means logging has become a thing of the past. Before, it was on us to track our own data, but now that data is automatically available. What does this mean for mHealth and the "connected" body?
In her session at @ThingsExpo, Lisa Calkins, CEO and co-founder of Amadeus Consulting, will discuss the impact of wea...
May. 4, 2016 10:00 AM EDT Reads: 1,121
In the world of DevOps there are ‘known good practices’ – aka ‘patterns’ – and ‘known bad practices’ – aka ‘anti-patterns.' Many of these patterns and anti-patterns have been developed from real world experience, especially by the early adopters of DevOps theory; but many are more feasible in theory than in practice, especially for more recent entrants to the DevOps scene.
In this power panel at @DevOpsSummit at 18th Cloud Expo, moderated by DevOps Conference Chair Andi Mann, panelists will dis...
May. 4, 2016 10:00 AM EDT Reads: 1,024
trust and privacy in their ecosystem. Assurance and protection of device identity, secure data encryption and authentication are the key security challenges organizations are trying to address when integrating IoT devices. This holds true for IoT applications in a wide range of industries, for example, healthcare, consumer devices, and manufacturing.
In his session at @ThingsExpo, Lancen LaChance, vice president of product management, IoT solutions at GlobalSign, will teach IoT developers how t...
May. 4, 2016 09:45 AM EDT Reads: 488
A critical component of any IoT project is the back-end systems that capture data from remote IoT devices and structure it in a way to answer useful questions. Traditional data warehouse and analytical systems are mature technologies that can be used to handle large data sets, but they are not well suited to many IoT-scale products and the need for real-time insights.
At Fuze, we have developed a backend platform as part of our mobility-oriented cloud service that uses Big Data-based approache...
May. 4, 2016 09:45 AM EDT Reads: 515
We're entering the post-smartphone era, where wearable gadgets from watches and fitness bands to glasses and health aids will power the next technological revolution. With mass adoption of wearable devices comes a new data ecosystem that must be protected. Wearables open new pathways that facilitate the tracking, sharing and storing of consumers’ personal health, location and daily activity data. Consumers have some idea of the data these devices capture, but most don’t realize how revealing and...
May. 4, 2016 09:30 AM EDT Reads: 502
Digital payments using wearable devices such as smart watches, fitness trackers, and payment wristbands are an increasing area of focus for industry participants, and consumer acceptance from early trials and deployments has encouraged some of the biggest names in technology and banking to continue their push to drive growth in this nascent market. Wearable payment systems may utilize near field communication (NFC), radio frequency identification (RFID), or quick response (QR) codes and barcodes...
May. 4, 2016 08:15 AM EDT Reads: 990